In genotype 3 patients, the IL28B CC genotype was associated with a two-fold increased risk of advanced liver fibrosis in the unadjusted analysis (OR 2.09, 95% CI 1.05–4.85)) compared to the CT/TT genotype. This evidence concerns the gene IFNL3 and Hepatic fibrosis.